Tefron Ltd.
TFRFF
$6.43
-$0.03-0.46%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 54.81M | 54.56M | 68.82M | 59.06M | 63.43M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 54.81M | 54.56M | 68.82M | 59.06M | 63.43M |
| Cost of Revenue | 43.89M | 44.34M | 54.17M | 46.23M | 50.36M |
| Gross Profit | 10.92M | 10.22M | 14.65M | 12.83M | 13.07M |
| SG&A Expenses | 7.94M | 8.77M | 8.02M | 7.97M | 8.58M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 397.00K | -- | -- | -- | 639.00K |
| Total Operating Expenses | 54.13M | 54.98M | 64.02M | 55.84M | 61.26M |
| Operating Income | 683.00K | -418.00K | 4.81M | 3.22M | 2.17M |
| Income Before Tax | 123.00K | -1.58M | 3.97M | 2.51M | 1.98M |
| Income Tax Expenses | 784.00K | 316.00K | 576.00K | 657.00K | 60.00K |
| Earnings from Continuing Operations | -661.00K | -1.90M | 3.39M | 1.86M | 1.92M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -661.00K | -1.90M | 3.39M | 1.86M | 1.92M |
| EBIT | 683.00K | -418.00K | 4.81M | 3.22M | 2.17M |
| EBITDA | 1.94M | 1.34M | 6.50M | 5.15M | 3.46M |
| EPS Basic | -0.05 | -0.15 | 0.27 | 0.15 | 0.15 |
| Normalized Basic EPS | 0.01 | -0.08 | 0.20 | 0.13 | 0.10 |
| EPS Diluted | -0.05 | -0.15 | 0.26 | 0.14 | 0.14 |
| Normalized Diluted EPS | 0.01 | -0.08 | 0.19 | 0.12 | 0.10 |
| Average Basic Shares Outstanding | 12.20M | 12.67M | 12.57M | 12.37M | 12.78M |
| Average Diluted Shares Outstanding | 12.20M | 12.67M | 13.05M | 13.25M | 12.96M |
| Dividend Per Share | -- | -- | -- | -- | 0.16 |
| Payout Ratio | 0.00% | -- | 60.70% | -- | 0.00% |